Fonar Corporation  

(Public, NASDAQ:FONR)   Watch this stock  
Find more results for FONR
11.41
0.00 (0.00%)
May 4 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 11.41 - 11.55
52 week 9.32 - 17.74
Open 11.41
Vol / Avg. 0.00/26,507.00
Mkt cap 73.41M
P/E 6.82
Div/yield     -
EPS 1.67
Shares 6.05M
Beta 1.50
Inst. own 19%

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 20.21% 19.56%
Operating margin 21.05% 17.98%
EBITD margin - 23.53%
Return on average assets 17.56% 17.87%
Return on average equity 34.01% 49.31%
Employees 430 -
CDP Score - -

Address

110 Marcus Dr
MELVILLE, NY 11747-4228
United States - Map
+1-631-6942929 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Fonar Corporation (Fonar) operates in two segments: medical equipment segment, conducted directly through Fonar and physician management and diagnostic services segment, conducted through its subsidiary Health Management Corporation of America (HMCA). The Company is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions and injuries. HMCA provides management services, administrative services, billing and collection services, office space, equipment, repair, maintenance service and clerical and other non-medical personnel to medical providers. The Company�s products include Upright MRI, a whole body open MRI system that enables positional MRI applications and the Fonar 360, an enlarged room sized magnet in which the floor, ceiling and walls of the scan room are part of the magnet frame.

Officers and directors

Raymond V. Damadian M.D. Chairman of the Board, President, Treasurer
Age: 77
Bio & Compensation  - Reuters
Claudette J. V. Chan Secretary, Director
Age: 75
Bio & Compensation  - Reuters
Charles N. O'Data Lead Independent Director
Age: 77
Bio & Compensation  - Reuters
Robert J. Janoff Independent Director
Age: 86
Bio & Compensation  - Reuters
Ronald G. Lehman Independent Director
Age: 37
Bio & Compensation  - Reuters